Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents can begin once a policy recommendation from the CDC is received
